Financial Assets and Financial Liabilities (Tables)
|
12 Months Ended |
Dec. 31, 2024 |
| Financial Instruments [Abstract] |
|
| Summary of Cash and Cash Equivalents |
| | | | | | | | | | | | | | | | | | | | | Cash at banks and on hand | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Summary of Financial Liabilities at Amortized Cost and at Fair Value through Profit or Loss |
Set out below is an overview of financial assets and liabilities at amortized cost and at fair value through OCI and profit or loss, as of the dates indicated: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through OCI | | | | | | | | | | | | | | | | | | | | | | | Non-listed equity investments | | | | | | | | | | | | | | | | | | | | | | | Listed equity investments | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as other financial assets | | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | | Cash at banks and on hand | | | | | | | | | | | | | | | | | | | | | | | Trade and other receivables | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at fair value | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trade payables and other payables | | | | | | | | | | | | | | | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently not measured according to IFRS 9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1)Fair values for financial assets and liabilities at amortized costs are not disclosed as the book values represent a reasonable approximation. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through OCI | | | | | | | | | | | | | | | | | | | | | | Non-listed equity investments | | | | | | | | | | | | | | | | | | | | | | Listed equity investments | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as other financial assets | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | Cash at banks and on hand | | | | | | | | | | | | | | | | | | | | | | Trade and other receivables | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at fair value | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trade payables and other payables | | | | | | | | | | | | | | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently not measured according to IFRS 9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1)Fair values for financial assets and liabilities at amortized costs are not disclosed as the book values represent a reasonable approximation. The maturity profile of our financial liabilities based on contractual undiscounted payments is summarized as follows: | | | | | | | | | | | | | | | | | | Year ended December 31, 2024 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | Year ended December 31, 2023 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | |
|
| Summary of Financial Liabilities at Amortized Cost |
Set out below is an overview of financial assets and liabilities at amortized cost and at fair value through OCI and profit or loss, as of the dates indicated: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through OCI | | | | | | | | | | | | | | | | | | | | | | | Non-listed equity investments | | | | | | | | | | | | | | | | | | | | | | | Listed equity investments | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as other financial assets | | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | | Cash at banks and on hand | | | | | | | | | | | | | | | | | | | | | | | Trade and other receivables | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at fair value | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trade payables and other payables | | | | | | | | | | | | | | | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently not measured according to IFRS 9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1)Fair values for financial assets and liabilities at amortized costs are not disclosed as the book values represent a reasonable approximation. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through OCI | | | | | | | | | | | | | | | | | | | | | | Non-listed equity investments | | | | | | | | | | | | | | | | | | | | | | Listed equity investments | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as other financial assets | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | Cash at banks and on hand | | | | | | | | | | | | | | | | | | | | | | Trade and other receivables | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at fair value | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trade payables and other payables | | | | | | | | | | | | | | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently not measured according to IFRS 9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1)Fair values for financial assets and liabilities at amortized costs are not disclosed as the book values represent a reasonable approximation. The maturity profile of our financial liabilities based on contractual undiscounted payments is summarized as follows: | | | | | | | | | | | | | | | | | | Year ended December 31, 2024 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | Year ended December 31, 2023 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | |
|
| Summary of Financial Assets at Amortized Cost and at Fair Value through Profit or Loss |
Set out below is an overview of financial assets and liabilities at amortized cost and at fair value through OCI and profit or loss, as of the dates indicated: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through OCI | | | | | | | | | | | | | | | | | | | | | | | Non-listed equity investments | | | | | | | | | | | | | | | | | | | | | | | Listed equity investments | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as other financial assets | | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | | Cash at banks and on hand | | | | | | | | | | | | | | | | | | | | | | | Trade and other receivables | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at fair value | | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trade payables and other payables | | | | | | | | | | | | | | | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently not measured according to IFRS 9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1)Fair values for financial assets and liabilities at amortized costs are not disclosed as the book values represent a reasonable approximation. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through profit or loss | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at fair value through OCI | | | | | | | | | | | | | | | | | | | | | | Non-listed equity investments | | | | | | | | | | | | | | | | | | | | | | Listed equity investments | | | | | | | | | | | | | | | | | | | | | | Financial assets subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as other financial assets | | | | | | | | | | | | | | | | | | | | | | Security investments disclosed as cash and cash equivalents | | | | | | | | | | | | | | | | | | | | | | Cash at banks and on hand | | | | | | | | | | | | | | | | | | | | | | Trade and other receivables | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at fair value | | | | | | | | | | | | | | | | | | | | | | Foreign exchange forward contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently measured at amortized costs(1) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trade payables and other payables | | | | | | | | | | | | | | | | | | | | | | Other financial liabilities | | | | | | | | | | | | | | | | | | | | | | Financial liabilities subsequently not measured according to IFRS 9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1)Fair values for financial assets and liabilities at amortized costs are not disclosed as the book values represent a reasonable approximation. Financial investments in equity securities measured at fair value through other comprehensive income comprise the following effects: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net gain / (loss) on equity instruments designated at fair value through other comprehensive income | | | | | | | | | | | | | | | | | | |
During the year ended December 31, 2024, the non-listed and listed equity investments increased by €41.1 million compared to year-end 2023 mainly due to our investment in Autolus Therapeutics plc in February 2024 and offsetting subsequent fair value changes amounting to €146.6 million during the year ended December 31, 2024.
|
| Summary of Significant Unobservable Inputs (Level 3) Used for Recurring Fair Value Measurements and the Effect of the Measurements |
The following table shows the recurring fair value measurement of the royalty assets included in other financial assets as well as contingent considerations and the effect of the measurements on our consolidated statements of profit or loss for the current period. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net effect on profit or loss - Finance income / (expense) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net effect on profit or loss - Finance income / (expense) | | | | | | | | | | | | | | | | | | | | | | | |
|
| Disclosure of fair value measurement of assets |
The following table shows the recurring fair value measurement of the royalty assets included in other financial assets as well as contingent considerations and the effect of the measurements on our consolidated statements of profit or loss for the current period. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net effect on profit or loss - Finance income / (expense) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net effect on profit or loss - Finance income / (expense) | | | | | | | | | | | | | | | | | | | | | | | |
|
| Summary of Significant Unobservable Inputs Used in Fair Value Measurement |
The following table shows the valuation techniques used in measuring fair values for financial instruments in our consolidated statements of financial position, as well as the significant unobservable inputs used. | | | | | | | | | | | | | | Significant unobservable inputs | | | | | | Forward exchange contracts | | Discounted cash flow using par method. Expected future cash flows based on foreign exchange forwards discounted over the respective remaining term of the contracts using the respective deposit interest rates and spot rates. | | | Non-listed equity investments | | Quantitative and qualitative factors such as actual and forecasted results, cash position and financing round valuations. | | –Actual and forecasted results –Net Asset Value –Cash position –Nature and pricing indication of latest financing round | Listed equity investments | | Stock prices of the listed companies and applicable exchange rates, if the listing is in a foreign currency. | | | | | Quoted prices on an active market. | | | | | Present value of expected future payments and reflecting changes in expected achievement of underlying performance parameters and compounding effects. | | –Expected future payments –Applied cost of capital | | | Present value of expected future cash flows. | | –Expected future cash flows –Applied cost of capital |
The sensitivity of the fair values of contingent considerations in fair value level 3 to the significant, unobservable, variable input factors, with all other factors remaining constant, is shown in the following table: Contingent consideration | | | | | | | | | | | | | | | | | | | | | | | | | | Change in fair value with increasing input factor (in millions €) | | | Change in fair value with decreasing input factor (in millions €) | | | | | | | | | | | | | | | | | | | | |
|
| Summary of Significant Unobservable Inputs (Level 3) Used for Recurring Fair Value Measurements and the Effect of the Measurements |
The sensitivity of the fair values of royalty assets included in other financial assets to the significant, unobservable, variable input factors, with all other factors remaining constant, is shown in the following table: Royalty assets | | | | | | | | | | | | | | | | | | | | | | | | | | Change in fair value with increasing input factor (in millions €) | | | Change in fair value with decreasing input factor (in millions €) | | | | | | | | | | | | | | | | | | | | |
|
| Summary of Carrying Amount of Monetary Assets |
The carrying amount of the monetary assets and liabilities denominated in U.S. dollar at the dates indicated are as follows: | | | | | | | | | | | | | | | | | | | | | Cash and cash equivalents in U.S. dollar | | | | | | | Monetary assets in U.S. dollar | | | | | | | Monetary liabilities and provisions in U.S. dollar | | | | | | | | | | | | | |
|
| Summary of Effect of Changes in Foreign Exchange Rates |
The following tables demonstrate the sensitivity to a reasonable, possible change in U.S. dollar exchange rates or U.S. dollar forward rates, with all other variables held constant. The impact on our profit before tax is due to changes in the fair value of monetary assets and liabilities. The exposure to foreign currency changes for all other currencies is not material. | | | | | | | | | | | | | | | | | | Change in U.S. dollar rate | | Effect on profit / (loss) before tax | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Summary of Changes in Liabilities Arising from Financing Activities |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, 2024 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Current obligations under lease contracts | | | | | | | | | | | | | | | Non-current obligations under lease contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, 2023 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Current obligations under lease contracts | | | | | | | | | | | | | | Non-current obligations under lease contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|